Skip to content

Theta Oscillation-Mediated Inhibitory Control in Social Attention Development of Young Children with Autism Spectrum Disorder: A Longitudinal Cohort Study

Theta Oscillation-Mediated Inhibitory Control in Social Attention Development of Young Children with Autism Spectrum Disorder: A Longitudinal Cohort Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500108560
Enrollment
Unknown
Registered
2025-09-01
Start date
2025-09-01
Completion date
Unknown
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autism Spectrum Disorder

Interventions

ASD:None

Sponsors

The Third Affiliated Hospital Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 3 Years

Inclusion criteria

Inclusion criteria: Children who are over 18 months old but under 24 months old, whose first language is Mandarin, and whose parents are willing to cooperate with the assessment and follow-up and have the ability to independently fill out questionnaires, are willing to undergo follow-up assessments at 24 months old, 30 months old, and 36 months old after their children are included in the study. For the ASD group, it is necessary to meet the DSM-5 diagnostic criteria for autism spectrum disorder, have significant social communication deficits and repetitive stereotyped behavior patterns, and the Autism Observational Diagnostic Scale indicates mild risk or above. For the TD group, it is necessary to have normal growth and development status, no obvious defects in social skills development, repetitive stereotyped behavior patterns, signs of delayed motor development or language development, and no previous diagnosis or suspicion of neurodevelopmental disorders.

Exclusion criteria

Exclusion criteria: 1. Diagnosed with syndromic autism such as Rett syndrome and fragile X syndrome; 2. Neurological disorders that affect the growth, development, or cognition of participants, such as central nervous system infections, epilepsy, etc; 3. Congenital heart disease, congenital metabolic disease; 4. Visual or hearing impairments, sensory impairments, or physical disabilities; 5. There is a clear perinatal cranial injury or disease, such as severe asphyxia, hypoxic encephalopathy, intracranial hemorrhage; or it may cause perinatal brain injury due to exposure to exogenous compounds such as alcohol and certain prescription drugs in the uterus.

Design outcomes

Primary

MeasureTime frame
Inhibitory Ability;EEG;Social Attention Capacity;

Countries

China

Contacts

Public ContactHongzhu Deng

The Third Affiliated Hospital Sun Yat-sen University

denghzh@mail.sysu.edu.cn+86 20 8217 9607

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026